Ann Lab Med.  2020 May;40(3):267-269. 10.3343/alm.2020.40.3.267.

Co-existence of VIM-2-producing Pseudomonas aeruginosa and KPC-2 and OXA-232-co-producing Klebsiella pneumoniae in the United States

• Palavecino E
• Ramirez K
• Greene SR
• Kilic A

• KMID: 2466022
• DOI: http://doi.org/10.3343/alm.2020.40.3.267

Abstract

No abstract available.

MeSH Terms

Klebsiella pneumoniae*
Klebsiella*
Pseudomonas aeruginosa*
Pseudomonas*
United States*

Reference

1. Livorsi DJ, Chorazy ML, Schweizer ML, Balkenende EC, Blevins AE, Nair R, et al. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Antimicrob Resist Infect Control. 2018; 7:55. PMID: 29719718.

2. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001; 45:1151–1161. PMID: 11257029.

3. Toleman MA, Rolston K, Jones RN, Walsh TR. bla_VIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob Agents Chemother. 2004; 48:329–332. PMID: 14693560.

4. Doi Y, O'Hara JA, Lando JF, Querry AM, Townsend BM, Pasculle AW, et al. Co-production of NDM-1 and OXA-232 by Klebsiella pneumoniae. Emerg Infect Dis. 2014; 20:163–165. PMID: 24377764.

5. Senchyna F, Gaur RL, Sandlund J, Truong C, Tremintin G, Kültz D, et al. Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a health care system in Northern California, from 2013 to 2016. Diagn Microbiol Infect Dis. 2019; 250–257. PMID: 30482638.

6. Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother. 2013; 57:130–136. PMID: 23070171.

7. Potron A, Rondinaud E, Poirel L, Belmonte O, Boyer S, Camiade S, et al. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae. Int J Antimicrob Agents. 2013; 41:325–329. PMID: 23305656.

8. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother. 2005; 49:3538–3540. PMID: 16048978.

9. Wang Y, Cao W, Zhu X, Chen Z, Li L, Zhang B, et al. Characterization of a novel Klebsiella pneumoniae sequence type 476 carrying both bla_KPC-2 and bla_IMP-4. Eur J Clin Microbiol Infect Dis. 2012; 31:1867–1872. PMID: 22271301.

10. CLSI. Performance standards for antimicrobial susceptibility testing, 29th ed. CLSI supplement M100-S29. Wayne, PA: Clinical and Laboratory Standards Institute;2019.